We initially compared the number of IFNγ-producing cells—as measured by ELISpot after stimulation of PBMC in vitro with a SARS-CoV-2 peptide library—between hospital staff members up to three months after vaccination and patients up to twelve months after infection (Figure 1A). The gene discussed is IFNG; the disease is infection.